Izmir protocol is safe, cheap and easy to carry out. “
“The greatest challenges of managing people with hemophilia (PWH) are in the developing countries. Not only do almost 80% of PWH reside in these find more countries but there is also significant lack of knowledge of this condition as well as diagnostic infrastructure and therapeutic options. Under these conditions, judicious utilization of resources becomes a matter of paramount importance with emphasis on early

diagnosis and physical therapy combined with best practises of factor replacement that is possible. However, the situation is rapidly evolving with greater allocation of resources for clotting factor concentrates (CFC) in large parts of the developing world. This has raised the possibility of initiating early prophylaxis with modest doses of CFC. These innovations do need to be combined with the classic concepts of comprehensive care to cover the management of chronic musculoskeletal complications and surgical interventions as needed. The introduction of molecular genetics click here for carrier detection and counseling is also very important. This chapter describes the comprehensive care model

for PWH in developing countries. “
“Summary.  Haemophilia A and B are rare X-linked conditions. Elevated rates of HIV and hepatitis C related malignancies in these patients are well reported, however rates of other types of cancers are not. Therefore,

a retrospective literature review of cancer in patients with haemophilia was conducted. A Medline search of articles from January 1966 to July 2009 utilizing the keywords haemophilia, leukaemia, malignancy, mortality, neoplasm and cancer was performed. The articles were reviewed and additional relevant publications were located from the references. Data on age, type and severity of haemophilia, HIV status, type of malignancy and outcomes were recorded as available. Thirty-two cases of leukaemia were identified as well as 159 malignant solid tumours. Specific incidence and prevalence rates could not be calculated due to the limited nature of the information available in the reports. Many types of malignancy have been reported in persons with haemophilia MCE irrespective of infection with HIV and hepatitis C yet prevalence and incidence rates compared to the general population remain unknown. Patients with haemophilia can manifest non infectious related malignancies and symptomatic patients should be evaluated accordingly. “
“Summary. Continuous infusion (CI) of factor VIII (FVIII) is an effective method for replacement therapy in haemophilia. Recently, concerns have been raised regarding association of CI with the development of inhibitors. The aim of this study was to gain information on the current practices in Europe regarding CI and the true inhibitor incidence after this mode of therapy.